GENOVA, Inc. (TYO:9341)
Japan
· Delayed Price · Currency is JPY | Market Cap | 16.87B |
| Revenue (ttm) | 10.19B |
| Net Income (ttm) | 1.87B |
| Shares Out | 17.30M |
| EPS (ttm) | 103.89 |
| PE Ratio | 9.39 |
| Forward PE | n/a |
| Dividend | 10.00 (1.03%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 299,200 |
| Average Volume | 125,880 |
| Open | 978.00 |
| Previous Close | 975.00 |
| Day's Range | 969.00 - 996.00 |
| 52-Week Range | 806.00 - 1,975.00 |
| Beta | -0.49 |
| RSI | 48.13 |
| Earnings Date | May 14, 2025 |
About GENOVA
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay mac... [Read more]
Financial Performance
In 2023, GENOVA's revenue was 8.68 billion, an increase of 33.32% compared to the previous year's 6.51 billion. Earnings were 1.73 billion, an increase of 36.98%.
Financial StatementsNews
Check Your Pantry ASAP for This Recalled Canned Tuna Brand
Tri-Union Seafoods announced a recall of canned tuna sold under the Trader Joe's, Genova, Van Camp's and H-E-B brand names due to quality and safety concerns.